ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.238,36
1,67%
S&P 500
5.746,45
0,42%
Dow Jones
42.205,79
0,69%
Euro vs US Dollar
1,11806
0,43%
Bitcoin
65.303,11
3,44%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Labcorp Holdings Inc (LH)

  7. Labcorp Holdings Inc (LH) News

LH

Labcorp (LH)

Labcorp Holdings Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:LH
DatumZeitQuelleÜberschriftSymbolFirma
24/09/202422h21Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
24/09/202422h16PR Newswire (US)Labcorp to Announce Third Quarter Financial Results on October 24, 2024NYSE:LHLabcorp Holdings Inc
23/09/202422h18Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
18/09/202422h05Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
18/09/202413h00PR Newswire (US)Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum ExperienceNYSE:LHLabcorp Holdings Inc
18/09/202412h12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:LHLabcorp Holdings Inc
17/09/202400h35PR Newswire (US)LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034NYSE:LHLabcorp Holdings Inc
16/09/202423h30Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:LHLabcorp Holdings Inc
16/09/202414h21Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:LHLabcorp Holdings Inc
16/09/202413h30PR Newswire (US)Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthNYSE:LHLabcorp Holdings Inc
03/09/202422h09PR Newswire (US)Labcorp to Speak at the Baird 2024 Global Healthcare ConferenceNYSE:LHLabcorp Holdings Inc
09/08/202416h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLabcorp Holdings Inc
05/08/202413h00PR Newswire (US)Labcorp Finalizes Acquisition of Select Assets of InvitaeNYSE:LHLabcorp Holdings Inc
02/08/202414h30PR Newswire (US)Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus DxNYSE:LHLabcorp Holdings Inc
01/08/202412h57PR Newswire (US)Labcorp Announces 2024 Second Quarter ResultsNYSE:LHLabcorp Holdings Inc
30/07/202413h00PR Newswire (US)Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing CapabilitiesNYSE:LHLabcorp Holdings Inc
25/07/202412h59PR Newswire (US)Labcorp Declares Quarterly DividendNYSE:LHLabcorp Holdings Inc
01/07/202413h00PR Newswire (US)Labcorp to Announce Second Quarter Financial Results on August 1, 2024NYSE:LHLabcorp Holdings Inc
17/06/202414h00PR Newswire (US)Labcorp Launches Global Trial Connect to Accelerate Clinical TrialsNYSE:LHLabcorp Holdings Inc
10/06/202414h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLabcorp Holdings Inc
04/06/202413h41Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
03/06/202423h23Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NYSE:LHLabcorp Holdings Inc
03/06/202413h00PR Newswire (US)Labcorp Announces New Strategic Service Offerings within Precision Oncology PortfolioNYSE:LHLabcorp Holdings Inc
30/05/202419h18Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:LHLabcorp Holdings Inc
30/05/202413h00PR Newswire (US)Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual MeetingNYSE:LHLabcorp Holdings Inc
28/05/202413h04Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
28/05/202412h59PR Newswire (US)Labcorp to Speak at the 44th Annual William Blair Growth Stock ConferenceNYSE:LHLabcorp Holdings Inc
17/05/202422h57Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:LHLabcorp Holdings Inc
17/05/202422h45Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:LHLabcorp Holdings Inc
17/05/202422h41Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNYSE:LHLabcorp Holdings Inc
 Showing the most relevant articles for your search:NYSE:LH

Kürzlich von Ihnen besucht

BOV
OCRE11
Octo Fundo de Investimen...
NASDAQ
CPAA
Conyers Park III Acquisi...
BIT
P1YHQ2
NLBNPIT1YHQ2 20351219 10...
TG
5AH
PHX Minerals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten